Diarrhea - Symptoms, Causes, Treatment & Prevention

```html

Overview

Diarrhea is the passage of loose, watery stools three or more times within a 24‑hour period. It is a common gastrointestinal complaint that affects people of all ages worldwide. In the United States, the CDC estimates that acute infectious diarrhea accounts for ≈ 19 million outpatient visits each year, while chronic diarrhea (lasting > 4 weeks) affects roughly 5 %–10 % of the adult population.<sup>1,2</sup> Diarrhea can be self‑limited and harmless, but it can also signal a serious underlying condition or lead to dangerous dehydration, especially in young children, older adults, and immunocompromised patients.

Symptoms

Symptoms may appear suddenly (acute) or develop gradually (chronic). Common features include:

• Frequent loose stools – watery, mushy, or liquid consistency.
• Abdominal cramping or pain – often colicky and relieved after a bowel movement.
• Urgency – a strong, sudden need to defecate.
• Fever – low‑grade (≤ 38 °C) in mild infections; higher fevers suggest bacterial or inflammatory causes.
• Nausea or vomiting – common with viral gastroenteritis.
• Bloody or mucous‑filled stool – raises concern for invasive bacterial infection, inflammatory bowel disease, or parasitic disease.
• Weight loss – especially in chronic diarrhea.
• Dehydration signs – dry mouth, decreased urine output, dizziness, tachycardia, or sunken eyes.
• Foul odor – may indicate malabsorption (e.g., lactose intolerance) or infection with certain bacteria (e.g., Clostridioides difficile).

Causes and Risk Factors

Diarrhea results from an imbalance between fluid absorption and secretion in the intestines. The underlying mechanisms differ by cause:

Infectious agents (≈ 80 % of acute cases)

• Viruses – Norovirus, rotavirus, adenovirus, astrovirus.
• Bacteria – Salmonella, Campylobacter, Shigella, Escherichia coli (ETEC, EHEC), Vibrio cholerae.
• Parasites – Giardia lamblia, Entamoeba histolytica, Cryptosporidium.

Non‑infectious causes

• Medication‑induced – antibiotics (especially broad‑spectrum), antacids containing magnesium, chemotherapy, certain laxatives.
• Food intolerances – lactose, fructose, sorbitol.
• Malabsorption syndromes – celiac disease, pancreatic exocrine insufficiency, short bowel syndrome.
• Inflammatory bowel disease (IBD) – ulcerative colitis, Crohn’s disease.
• Irritable bowel syndrome (IBS) – diarrhea‑predominant subtype (IBS‑D).
• Endocrine disorders – hyperthyroidism, Addison’s disease.
• Systemic illnesses – HIV/AIDS, chemotherapy‑induced mucositis.

Risk factors

• Age < 5 years and > 65 years (higher dehydration risk).
• Recent travel to low‑ and middle‑income countries (travelers’ diarrhea).
• Immunosuppression (HIV, organ transplant, steroids).
• Recent or ongoing antibiotic therapy (risk for C. difficile).
• Chronic gastrointestinal disease (IBD, celiac).
• Living in or consuming food/water from areas with poor sanitation.

Diagnosis

Most acute diarrheas are diagnosed clinically, but specific testing guides treatment when red‑flag features are present.

History and physical examination

• Onset, duration, stool frequency, appearance (bloody, greasy, frothy).
• Associated symptoms (fever, vomiting, weight loss, abdominal pain).
• Recent travel, food intake, medication use, sick contacts.
• Signs of dehydration or systemic illness.

Laboratory and stool studies

• Stool culture – bacterial pathogens, especially if bloody diarrhea or severe illness.
• Stool PCR panels – rapid detection of multiple viruses, bacteria, and parasites (CDC’s FoodNet recommends when available).
• Clostridioides difficile toxin assay – for patients with recent antibiotics or healthcare exposure.
• Fecal leukocytes or lactoferrin – markers of inflammation, suggestive of invasive infection or IBD.
• Ova and parasite exam – indicated for travel‑related or prolonged diarrhea.

Blood tests

• Complete blood count (CBC) – assess for leukocytosis.
• Electrolytes, BUN/creatinine – evaluate dehydration and renal function.
• C-reactive protein (CRP) or erythrocyte sedimentation rate (ESR) – inflammatory markers.
• Serology for celiac disease (tTG‑IgA) if malabsorption suspected.

Imaging and endoscopy

• Abdominal CT or ultrasound – reserved for severe abdominal pain or suspected complications (e.g., toxic megacolon).
Colonoscopy or upper endoscopy – indicated for chronic diarrhea when inflammatory, neoplastic, or microscopic colitis is suspected.

Treatment Options

Treatment is tailored to the underlying cause, severity, and patient risk profile.

General measures

• Fluid replacement – oral rehydration solution (ORS) containing 2.6 g NaCl, 1.5 g KCl, 2.9 g trisodium citrate, and 13.5 g glucose per litre (WHO formula) or commercial ORS packets.
• For adults with mild‑moderate dehydration, 1–2 L of ORS over 4‑6 hours is usually sufficient; children require weight‑based dosing (≈ 75 mL/kg in 4 hours).
• Continue a normal diet; the “BRAT” diet (bananas, rice, applesauce, toast) is outdated and unnecessarily restrictive.

Pharmacologic therapy

• Antimotility agents – Loperamide 2 mg initially, then 2 mg after each loose stool (max 8 mg/24 h). Contraindicated in dysentery, high fever, or C. difficile infection.
• Adsorbents – Bismuth subsalicylate 525 mg every 30–60 min (max 8 g/24 h). Provides antimicrobial and anti‑inflammatory effects; avoid in aspirin‑allergic patients.
• Antibiotics – Reserved for invasive bacterial diarrhea, traveler’s diarrhea, or high‑risk patients.
• Travelers’ diarrhea: Azithromycin 500 mg single dose or 1 g once daily for 3 days.
• Severe Campylobacter or Shigella: Ciprofloxacin 500 mg BID for 3‑5 days.
• C. difficile: Vancomycin 125 mg PO QID for 10 days (first‑line per IDSA guidelines).<sup>3</sup>
• Probiotics – Strains such as Lactobacillus rhamnosus GG or Saccharomyces boulardii may shorten duration of viral or antibiotic‑associated diarrhea (evidence Level B).
• Targeted therapy for chronic causes –
  • IBD: 5‑ASA, corticosteroids, immunomodulators, biologics.
  • IBS‑D: Low‑dose tricyclic antidepressants, rifaximin 550 mg TID for 14 days.
  • Lactose intolerance: Lactase enzyme supplements.

Procedural interventions

• Intravenous (IV) rehydration with isotonic saline or lactated Ringer’s for severe dehydration, hypotension, or inability to tolerate oral fluids.
• In refractory cases of C. difficile, fecal microbiota transplantation (FMT) is recommended after a second recurrence.

Living with Diarrhea

Even when the acute episode resolves, many patients experience occasional bouts or chronic symptoms. Below are practical strategies for day‑to‑day management:

• Hydration tracking – Aim for 1.5–2 L of fluid per day (more with ongoing loss). Include ORS or electrolyte‑rich beverages (e.g., sports drinks, clear broths).
• Dietary adjustments –
  • Consume low‑fat, low‑fiber “gentle” foods while symptoms persist (e.g., boiled potatoes, rice, plain yogurt).
  • Gradually re‑introduce fiber (soluble fiber such as oats or psyllium) as stools normalize.
  • Identify and avoid personal trigger foods (lactose, gluten, high‑fructose corn syrup).
• Medication timing – If taking antidiarrheal medication, limit use to ≤ 48 hours unless directed by a clinician.
• Hygiene – Wash hands with soap for at least 20 seconds after bathroom use and before food preparation. Use alcohol‑based hand sanitizer only when soap is unavailable.
• Travel precautions –
  • Drink bottled or boiled water, avoid ice cubes, and eat thoroughly cooked foods.
  • Consider a prophylactic dose of bismuth subsalicylate before high‑risk meals.
• Monitoring weight – Weigh yourself daily; a loss > 5 % of body weight signals dehydration or malabsorption needing medical review.
• Supportive care for chronic disease – Keep a symptom diary (frequency, stool form using the Bristol Stool Chart, triggers) to discuss with your gastroenterologist.

Prevention

Many cases of diarrhea are preventable with simple public‑health and personal‑behavior measures.

• Food safety – Cook meats to internal temperatures of ≥ 165 °F (74 °C), wash fruits/vegetables thoroughly, refrigerate perishable foods within 2 hours.
• Water safety – Use filtered, boiled, or chemically treated water when quality is uncertain.
• Vaccination – Rotavirus vaccine for infants (two‑dose series) reduces severe childhood diarrhea by ≈ 85 % (CDC). Typhoid and cholera vaccines are recommended for travelers to endemic regions.
• Antibiotic stewardship – Use antibiotics only when prescribed for a bacterial infection; avoid unnecessary broad‑spectrum agents.
• Hand hygiene – The single most effective measure for reducing viral gastroenteritis (up to 35 % reduction in community settings).
• Probiotic use in high‑risk groups – Some studies suggest that probiotic prophylaxis can lower the incidence of antibiotic‑associated diarrhea in hospitalized patients.

Complications

If left unchecked, diarrhea can lead to serious health problems, especially in vulnerable populations.

• Dehydration and electrolyte imbalance – Hyponatremia, hypokalemia, metabolic acidosis; can cause seizures, cardiac arrhythmias, or acute kidney injury.
• Malnutrition – Chronic diarrhea impairs absorption of macronutrients and micronutrients (e.g., vitamin A, zinc), leading to growth failure in children.
• Hemolytic‑uremic syndrome (HUS) – Associated with Shiga‑toxin‑producing E. coli O157:H7; presents with anemia, thrombocytopenia, and renal failure.
• Toxic megacolon – Rare but life‑threatening colonic dilation seen in severe ulcerative colitis or C. difficile infection.
• Sepsis – Invasive bacterial pathogens can translocate across the inflamed gut barrier.

When to Seek Emergency Care

---

References:

1. Mayo Clinic. “Diarrhea.” Updated 2023. https://www.mayoclinic.org
2. CDC. “Acute Diarrheal Disease.” 2022. https://www.cdc.gov
3. Infectious Diseases Society of America. “Clinical Practice Guidelines for Clostridioides difficile Infection.” 2021. https://www.idsociety.org
4. World Health Organization. “Oral Rehydration Salts (ORS) – Formulation.” 2021. https://www.who.int
5. Cleveland Clinic. “Travelers’ Diarrhea.” 2023. https://my.clevelandclinic.org

```